Terms: = Brain cancer AND DDB2, Q92466, 1643, ENSG00000134574, FLJ34321 AND Prognosis
4 results:
1. Quantitative Proteomics Analysis Reveals Nuclear Perturbation in Human Glioma U87 Cells treated with Temozolomide.
Guo J; Yi GZ; Liu Z; Sun X; Yang R; Guo M; Li Y; Li K; Li K; Wang X; Song H; Qi S; Huang G; Liu Y
Cell Biochem Funct; 2020 Mar; 38(2):185-194. PubMed ID: 31833081
[TBL] [Abstract] [Full Text] [Related]
2. Timing of brain metastases development in metastatic renal cell cancer patients treated with targeted therapies and survival outcomes: An Australian multicenter study.
Ha FJ; Spain L; Dowling A; Kwan EM; Pezaro C; Day D; Chia PL; Tran B; Pook D; Weickhardt AJ
Asia Pac J Clin Oncol; 2019 Oct; 15(5):e97-e102. PubMed ID: 30701671
[TBL] [Abstract] [Full Text] [Related]
3. NRF1 motif sequence-enriched genes involved in ER/PR -ve HER2 +ve breast cancer signaling pathways.
Ramos J; Das J; Felty Q; Yoo C; Poppiti R; Murrell D; Foster PJ; Roy D
Breast Cancer Res Treat; 2018 Nov; 172(2):469-485. PubMed ID: 30128822
[TBL] [Abstract] [Full Text] [Related]
4. Expression signatures of DNA repair genes correlate with survival prognosis of astrocytoma patients.
de Sousa JF; Torrieri R; Serafim RB; Di Cristofaro LF; Escanfella FD; Ribeiro R; Zanette DL; Paçó-Larson ML; da Silva WA; Tirapelli DP; Neder L; Carlotti CG; Valente V
Tumour Biol; 2017 Apr; 39(4):1010428317694552. PubMed ID: 28378638
[TBL] [Abstract] [Full Text] [Related]
